Immune cartography of macrophage activation syndrome in the COVID-19 era | Nature Reviews Rheumatology
National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
SciELO - Brasil - CLINICAL-EPIDEMIOLOGICAL RELATION BETWEEN SARS-COV-2 AND KAWASAKI DISEASE: AN INTEGRATIVE LITERATURE CLINICAL-EPIDEMIOLOGICAL RELATION BETWEEN SARS-COV-2 AND KAWASAKI DISEASE: AN INTEGRATIVE LITERATURE
Giant coronary aneurysms in infants with Kawasaki disease | Anales de Pediatría
Eric Topol on Twitter: "Just out @TheLancet: The children with Kawasaki disease from #SARSCoV2 A unique report from Italy comparing this to pre-#COVID19: the incidence has gone up 30-fold and it is
Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches | SpringerLink
A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns | BMC Infectious Diseases | Full Text
Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience - The Journal of Pediatrics
Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches | SpringerLink
Long-term Consequences of Kawasaki Disease | Circulation
Frontiers | Kawasaki Disease and Systemic Juvenile Idiopathic Arthritis – Two Ends of the Same Spectrum | Pediatrics
Kawasaki Disease Clinic - Stanford Children's Health
PDF) Kawasaki disease shock syndrome complicated with macrophage activation syndrome in a 5-month old boy: A case report
Kawasaki-like disease increase in Italian COVID-19 epicenter | 2 Minute Medicine
Prevalence of Kawasaki Disease in Young Adults With Suspected Myocardial Ischemia | Circulation
Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment | SpringerLink
SARS-CoV-2–Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children | American Academy of Pediatrics
PDF) Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease
Kawasaki Disease - Current Understanding of the Mechanism and Evidence-Based Treatment | Ben Tsutomu Saji | Springer
Kawasaki-like disease: emerging complication during the COVID-19 pandemic - The Lancet
